Comparable stake leader
Alumni Capital LP
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001527352.
Comparable stake leader
Alumni Capital LP
Disclosed value leader
Marilyn Elson
Comparable rows
2/32
Latest evidence
19 Aug 2026
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Quick read
2 of 32 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Alumni Capital LP |
13D/G
|
10%
Reported 13D/G
· 19 Aug 2026
|
$847,646
2,493,075 shares
|
$0 | 19 Aug 2026 |
| Greenlight Ventures, LLC |
13D/G
|
5.6%
Reported 13D/G
· 18 Aug 2026
|
—
1,385,246 shares
|
$0 | 18 Aug 2026 |
| Marilyn Elson |
3/4/5
10%+ Owner
|
—
mixed-class rows
|
$1,460,445
2,084,094 shares
mixed-class rows
|
— | 10 Sep 2025 |
| Leonard Osser |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$1,311,047
1,618,577 shares
|
— | 29 Sep 2025 |
| Ben Hu |
3/4/5
Director
|
—
mixed-class rows
|
$305,446
477,095 shares
mixed-class rows
|
— | 19 Dec 2025 |
| Rick Morad |
3/4/5
Director
|
—
denominator unverified
|
$190,541
170,126 shares
|
— | 16 Sep 2022 |
| David Owens |
3/4/5
Chief Medical Officer, Director
|
—
mixed-class rows
|
$154,914
2,676,061 shares
mixed-class rows
|
— | 19 Dec 2025 |
| Alan Kazden |
3/4/5
Director
|
—
mixed-class rows
|
$96,867
482,090 shares
mixed-class rows
|
— | 19 Dec 2025 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
No eligible buy or sell activity is available for this window. No eligible Buy or Sell transactions are available in this dataset since 01 Nov 2025.
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Showing 1-10 of 10 reporting-owner rows connected to Nexalin Technology, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Marilyn Elson | 10%+ Owner | $1,460,445 | Mixed | 10 Sep 2025 | ||
| Leonard Osser | 10%+ Owner | $1,311,047 | Mixed | 29 Sep 2025 | ||
| Ben Hu | Director | $305,446 | Mixed | 19 Dec 2025 | ||
| Rick Morad | Director | $190,541 | Mixed | 16 Sep 2022 | ||
| David Owens | Chief Medical Officer, Director | $154,914 | Mixed | 19 Dec 2025 | ||
| Alan Kazden | Director | $96,867 | Mixed | 19 Dec 2025 | ||
| Carolyn Hamby Shelton | Sr. VP - Quality - Regulatory | $66,000 | Filing P/S | 19 Dec 2025 | ||
| Leslie Bernhard | Director | $47,346 | Mixed | 30 Sep 2024 | ||
| Justin van Fleet | Cfo | $24,750 | Mixed | 19 Dec 2025 | ||
| Mark White | CEO, Director | Mixed | 19 Dec 2025 |
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Mark White | NXL | Stock Option (right to buy)* | Award | 72.1% | 1,000,000 | 2,387,024 | 19 Dec 2025 | Direct | ||
| Justin van Fleet | NXL | Stock Option (right to buy)* | Award | 76.7% | 100,000 | 230,435 | 19 Dec 2025 | Direct | ||
| David Owens | NXL | Stock Option (right to buy)* | Award | 67.4% | 1,000,000 | 2,484,809 | 19 Dec 2025 | Direct | ||
| Carolyn Hamby Shelton | NXL | Stock Option (right to buy)* | Award | 90.4% | 100,000 | 210,620 | 19 Dec 2025 | Direct | ||
| Ben Hu | NXL | Stock Option (right to buy)* | Award | 100,000 | 100,000 | 19 Dec 2025 | Direct | |||
| Alan Kazden | NXL | Stock Option (right to buy)* | Award | 38.1% | 100,000 | 362,500 | 19 Dec 2025 | Direct |